AI assistant
Sending…
OPKO Health Inc. — Report Publication Announcement 2021
Apr 27, 2021
6963_rns_2021-04-27_95d47dd5-251b-4a96-ba8c-8828dc991277.htm
Report Publication Announcement
Open in viewerOpens in your device viewer
Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year���� ������� ������ ����� �� ���� ������� ���� false
| ����� ���', ���� | 2 380 |
| OPKO HEALTH, INC | |
| Corporation no: 2279206 | 13156 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 27/04/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-072171 | Time of broadcast: 17:46 17:46 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onMajor League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year ���� ������� ������ ����� �� ���� ������� ������ �� ���� BioReference
20210427_PR_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ GSM | Date of revision of form structure: 20/04/2021 |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Israel , Tel: 08-9300051 , Fax: 08-9543101 | |
| E-mail address: [email protected] Company site: Www.Opko.Com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Faibish Gabriel Position of Signatory in the reporting corporation: General Counsel Name of Employer Company: | |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Telephone: 08-9300051 Facsimile: 08-9300091 E-mail: [email protected] 1 | |
More from OPKO Health Inc.
Regulatory Filings
2026
Jul 2
Major Shareholding Notification
2026
Jul 2
Director's Dealing
2026
Jun 23
Director's Dealing
2026
Jun 23
Director's Dealing
2026
Jun 23
Director's Dealing
2026
Jun 23
Regulatory Filings
2026
Jun 23
Director's Dealing
2026
Jun 23
Director's Dealing
2026
Jun 23
Director's Dealing
2026
Jun 23